Correction to: Oncogene
After publication of this article, the authors noted that an incorrect image of N-cadherin was included in Fig. 5f for the DMS114 LV-SOX2 vehicle group.
▓.
The figure has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The original article can be found online at https://doi.org/10.1038/s41388-018-0311-3.
Rights and permissions
About this article
Cite this article
Wang, K., Ji, W., Yu, Y. et al. Correction: FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer. Oncogene 39, 6619–6620 (2020). https://doi.org/10.1038/s41388-020-01441-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-020-01441-6
This article is cited by
-
Jiedu Fuzheng decoction improves the proliferation, migration, invasion and EMT of non-small cell lung cancer via the Wnt/β-catenin pathway
Cell Division (2023)
-
FGFR1 is a potential therapeutic target in neuroblastoma
Cancer Cell International (2022)
